In-Person Registration for Industry Professionals | What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma
Submissions for this form are closed.
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of lymphoma.